DAY ONE BIOPHARMACEUTICALS

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages. The company understands that advances in cancer research now enable drug developers to identify children and adults who may benefit from the same medicine. They develop new therapies that meet the critical needs of people of all ages living with cancer starting from the biology of childhood cancer. Day One Biopharmaceuticals also focuses its efforts to bring the best m... edicines to families receiving the life-altering news of a new cancer diagnosis and the need for a treatment plan. It prioritizes programs that can be rapidly brought to market for both younger and older patients. The company's goal is to license and acquire the most promising products from research institutions as well as for biotechnology and pharmaceutical companies. Day One Biopharmaceuticals was founded in 2018 and is headquartered in South San Francisco, CA, USA.

#SimilarOrganizations #People #Financial #Website #More

DAY ONE BIOPHARMACEUTICALS

Social Links:

Industry:
Biopharma Biotechnology Health Care Pharmaceutical

Founded:
2018-11-01

Address:
South San Francisco, California, United States

Country:
United States

Website Url:
http://www.dayonebio.com

Total Employee:
51+

Status:
Active

Contact:
+1 650 484 0899

Email Addresses:
info@dayonebio.com

Total Funding:
362.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome


Similar Organizations

clover-biopharmaceuticals-logo

Clover Biopharmaceuticals

Clover Biopharmaceuticals is a clinical-stage biotechnology company focused on developing vaccines and biologic therapeutic.

regeneron-logo

Regeneron

Regeneron Pharmaceuticals is a biotechnology company that invents life-transforming medicines for people with serious diseases.

roivant-sciences-logo

Roivant Sciences

Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.

umoja-biopharma-logo

Umoja Biopharma

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

wren-therapeutics-logo

Wren Therapeutics

Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.


Current Advisors List

derek-dirocco_image

Derek DiRocco Board Member @ Day One Biopharmaceuticals
Board_member
2021-02-10

natalie-holles_image

Natalie Holles Director @ Day One Biopharmaceuticals
Board_member
2021-01-01

Current Employees Featured

jeremy-bender_image

Jeremy Bender
Jeremy Bender Chief Executive Officer @ Day One Biopharmaceuticals
Chief Executive Officer
2020-09-01

samuel-blackman_image

Samuel Blackman
Samuel Blackman Co-Founder and CMO @ Day One Biopharmaceuticals
Co-Founder and CMO
2018-11-01

mike-preigh_image

Mike Preigh
Mike Preigh CTO @ Day One Biopharmaceuticals
CTO

sharon-tetlow_image

Sharon Tetlow
Sharon Tetlow Consulting Chief Financial Officer @ Day One Biopharmaceuticals
Consulting Chief Financial Officer

julie-papanek-grant_image

Julie Papanek Grant
Julie Papanek Grant Co-Founder & Chief Executive Officer @ Day One Biopharmaceuticals
Co-Founder & Chief Executive Officer
2018-11-01

jaa-roberson_image

Jaa Roberson
Jaa Roberson Chief People Officer @ Day One Biopharmaceuticals
Chief People Officer
2021-09-01

Founder


julie-papanek-grant_image

Julie Papanek Grant

samuel-blackman_image

Samuel Blackman

Stock Details


Company's stock symbol is NASDAQ:DAWN

Investors List

atlas-venture_image

Atlas Venture

Atlas Venture investment in Series B - Day One Biopharmaceuticals

franklin-templeton-investments_image

Franklin Templeton Investments

Franklin Templeton Investments investment in Series B - Day One Biopharmaceuticals

janus-henderson-investors_image

Janus Henderson Investors

Janus Henderson Investors investment in Series B - Day One Biopharmaceuticals

t-rowe-price_image

T. Rowe Price

T. Rowe Price investment in Series B - Day One Biopharmaceuticals

canaan-partners_image

Canaan Partners

Canaan Partners investment in Series B - Day One Biopharmaceuticals

access-biotechnology_image

Access Biotechnology

Access Biotechnology investment in Series B - Day One Biopharmaceuticals

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series B - Day One Biopharmaceuticals

boxer-capital_image

Boxer Capital

Boxer Capital investment in Series B - Day One Biopharmaceuticals

viking-global-investors_image

Viking Global Investors

Viking Global Investors investment in Series B - Day One Biopharmaceuticals

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series B - Day One Biopharmaceuticals

Official Site Inspections

http://www.dayonebio.com Semrush global rank: 2.7 M Semrush visits lastest month: 6.15 K

  • Host name: 198.185.159.144
  • IP address: 198.185.159.144
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Day One Biopharmaceuticals"

Cancer Therapies for Children & Adults | Day One

We are a growing company of passionate oncologists, scientists, professionals and business leaders unafraid to disrupt the status quo of traditional drug development to get better, …See details»

Our Company | Day One Biopharmaceuticals

You are now leaving the Day One Biopharmaceuticals Corporate WebsiteSee details»

Our Leadership Team | Day One Biopharmaceuticals

In addition to serving on the Bristol Myers Squibb’s management team, Adam previously served as the Company’s Lead Counsel for the Global Research and Development organization. Prior …See details»

Investor Relations - Day One Biopharmaceuticals, Inc.

Company Overview. Day One Biopharmaceuticals is a commercial-stage company focused on advancing first- or best-in-class medicines for childhood and adult diseases with equal intensity.See details»

Day One Biopharmaceuticals - Crunchbase Company …

Contact Email info@dayonebio.com Phone Number +1 650 484 0899 Day One Biopharmaceuticals is a biotechnology company that focuses on developing …See details»

Day One Biopharmaceuticals, Inc. (DAWN) - Yahoo Finance Canada

See the company profile for Day One Biopharmaceuticals, Inc. (DAWN) including business summary, industry/sector information, number of employees, business summary, corporate …See details»

Day One Biopharmaceuticals | LinkedIn

Day One Biopharmaceuticals is a commercial-stage company focused on advancing first- or best-in-class medicines for childhood and adult diseases with equal intensity.See details»

Day One Biopharmaceuticals CEO and Key Executive Team

Day One Biopharmaceuticals's Chief Executive Officer and Director is Jeremy Bender. Other executives include Lisa Bowers, Chief Commercial Officer; Mike Preigh, Chief of Technology …See details»

Day One Biopharmaceuticals

For full prescribing information, visit dayonebio.com *This indication is approved under accelerated approval based on response rate and duration of response. Continued approval …See details»

Mission | Day One Biopharmaceuticals

At Day One, we are focused on advancing first- or best-in-class medicines for childhood and adult diseases with equal intensity. We were founded to address the lack of new therapies resulting …See details»

Day One Biopharmaceuticals - workinbiotech.com

Day One Biopharmaceuticals is developing therapies for patients of all ages with life-threatening diseases. The most common childhood brain cancer is pediatric low-grade glioma (pLGG), …See details»

Day One - 2025 Company Profile, Funding & Competitors - Tracxn

Mar 18, 2025 Day One - Developer of drugs for treating cancer. Public Company. Raised a total funding of $190M over 2 rounds from 11 investors. Founded by Julie Grant and Sam …See details»

Day One Biopharmaceuticals - Craft

Revenue (Q3, 2024)$93.8M Net income (Q3, 2024)$37.0M Cash (Q3, 2024)$422.8M EBIT (Q3, 2024)$29.6M Enterprise value $1.0BSee details»

Release Details - ir.dayonebio.com

Nov 20, 2024 Dr. Blackman’s departure planned for end of 2024. Company’s search for a new Head of R&D is ongoing. BRISBANE, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Day One …See details»

Childhood cancer-focused Day One snags Gilead alum Bender for …

Sep 23, 2020 Day One Biopharmaceuticals emerged in May to develop new drugs specifically for children with cancer. Now, as it ramps up its work, the company is making a flurry of new …See details»

Our Culture | Careers | Day One Biopharmaceuticals

Explore the collaborative, values-driven culture at Day One. Learn how our shared mission, guided by passion and purpose, empowers employees to make a meaningful impact for patients.See details»

Cancer Treatments for Kids - The Medicine Maker

Jun 1, 2023 Why are you passionate about pediatric oncology? Two aspects of developing new medicines for children living with cancer motivate me. The first is the opportunity to positively …See details»

Open positions | Day One

Due to recent phishing attempts occurring through certain job seeking platforms such as LinkedIn, Day One requests that any job seekers use caution when receiving interview requests, job …See details»

Associate Director, Marketing Science and Sales Operations

ASSOCIATE DIRECTOR, MARKETING SCIENCE AND SALES OPERATIONS Day One Biopharmaceuticals is an emerging, mission-driven, drug development company intentionally …See details»

Release Details - ir.dayonebio.com

BRISBANE, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing …See details»

linkstock.net © 2022. All rights reserved